Genetic variation in the B-type natiuretic peptide pathway affects BNP levels

Cardiovascular Drugs and Therapy

Volumn 21, Issue 1, 2007, Pages 55-62

  Lanfear, David E ^a   Stolker, Joshua M ^b   Marsh, Sharon ^b   Rich, Michael W ^b   McLeod, Howard L ^c  

^a HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of North Carolina   (United States)

Author keywords

BNP; Genetics; Heart failure; Left ventricular end diastolic pressure; Natriuretic peptides

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; TROPONIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DNA EXTRACTION; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; EXON; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC VARIABILITY; GENOTYPE; HEART CATHETERIZATION; HEART FAILURE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NATRIURETIC PEPTIDE PRECURSOR B GENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

AFRICAN AMERICANS; AGED; ALLELES; CARDIOVASCULAR DISEASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NATRIURETIC PEPTIDE, BRAIN; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION;

EID: 34247137974     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-007-6007-5     Document Type: Article

References (32)

1. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002;39:60-9.
2. Heart Disease and Stroke Statistics - 2005 Update. American Heart Association, 2004. (Accessed 2004, at http://www.americanheart.org/presenter. jhtml?identifier=1928.)
3. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-18.
4. Chen HH, Burnett JC, Jr. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials. Proc Assoc Am Physicians 1999;111:406-16.
5. Stolker JM, Rich MW. B-type natriuretic peptide provides independent and incremental value in predicting left ventricular end-diastolic pressure in elderly patients. Am J Geriatric Cardiol 2005;14:109.
6. Stolker JM, Rich MW. The combination of B-type natriuretic peptide and C-reactive protein provides incremental value in predicting outcomes among older patients referred for cardiac catheterization. Am J Geriatric Cardiol 2005;14:109-10.
7. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362:316-22.
8. Drazner MH, de Lemos JA. Unexpected BNP levels in patients with advanced heart failure: a tale of caution and promise. Am Heart J 2005;149:187-9.
9. Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty H, Morehead A, et al. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 2004;43:416-22.
10. Nabel EG. Cardiovascular disease. N Engl J Med 2003;349:60-72.
11. Evans WE, McLeod HL. Pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med 2003;348:538-49.
12. Wang TJ, Larson MG, Levy D, Benjamin EL, Corey D, Leip EP, et al. Heritability and genetic linkage of plasma natriuretic peptide levels. Circulation 2003;108:13-6.
13. Lanfear DE, Marsh S, McLeod HL. Sequence variants of natriuretic peptide receptor C are common and their frequency differs between African Americans and European Americans. J Card Fail 2004;10:S59.
14. Rehemudula D, Nakayama T, Soma M, Takahashi Y, Uwabo J, Sato M, et al. Structure of the type B human natriuretic peptide receptor gene and association of a novel microsatellite polymorphism with essential hypertension. Circ Res 1999;84:605-10.
15. Rahmutula D, Nakayama T, Soma M, Kosuge K, Aoi N, Izumi Y, et al. Structure and polymorphisms of the human natriuretic peptide receptor C gene. Endocrine 2002;17:85-90.
16. Rahmutula D, Nakayama T, Soma M, Takahasji Y, Kunimoto M, Uwabo J, et al. Systematic screening of type B human natriuretic peptide receptor gene polymorphisms and association with essential hypertension. J Hum Hypertens 2001;15:471-4.
17. Knowles JW, Erickson LM, Guy VK, Sigel CS, Wilder JC, Maeda N. Common variations in noncoding regions of the human natriuretic peptide receptor A gene have quantitative effects. Hum Genet 2003;112:62-70.
18. Nakayama T, Soma M, Saito S, Honye J, Sato M, Aio N, et al. Missense mutation of exon 3 in the type A human natriuretic peptide receptor gene is associated with myocardial infarction. Med Sci Monit 2003;9:CR505-10.
19. Pitzalis MV, Sarzani R, Dessi-Fulgheri P, Lacoviello M, Forleo C, Lucarelli K, et al. Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype. J Hypertens 2003;21:1491-6.
20. Nakayama T, Soma M, Takahashi Y, Rehemudula D, Kanmatsuse K, Furuya K. Functional deletion mutation of the 5′-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. Circ Res 2000;86:841-5.
21. Aoi N, Soma M, Nakayama T, Rahmutula D. Kosuge K, Izumi Y, et al. Variable number of tandem repeat of the 5′-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension. Hypertens Res 2004;27:711-6.
22. Lanfear DE, Marsh S, Cresci S, Shannon WD, Spertus JA, McLeod HL. Genotypes associated with myocardial infarction risk are more common in African Americans than in European Americans. J Am Coll Cardiol 2004;44:165-7.
23. Stoupakis G, Klapholz M. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure. Heart Dis 2003;5:215-23.
24. Freimuth RR, Stormo GD, McLeod HL. PolyMAPr: programs for polymorphism database mining, annotation, and functional analysis. Hum Mutat 2005;25:110-7.
25. The International HapMap Project. Nature 2003;426:789-96.
26. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
27. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
28. Marsh S, King CR, Garsa AA, McLeod HL. Pyrosequencing of clinically relevant polymorphisms. Methods Mol Biol 2005;311:97-114.
29. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-34.
30. LaPointe MC. Molecular regulation of the brain natriuretic peptide gene. Peptides 2005:944-56.
31. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 2004;32:D91-4.
32. Palmer BR, Frampton CM, Richards AM, Cameron VA, Nakayama T. Absence of a NPR-A gene functional deletion allele in a postmyocardial infarction cohort from New Zealand. Circ Res 2004;94:e86.